CYP2A6 and CYP2E1 polymorphisms in a Brazilian population living in Rio de Janeiro

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 2, 2006, Pages 195-201

  Rossini, A ^a   Soares Lima, S ^a   Rapozo, D C M ^a   Faria, M ^a   Albano, R M ^a   Ribeiro Pinto, L F ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Brazil; CYP2A6; CYP2E1; Ethnic groups; Polymorphism

Indexed keywords

CYTOCHROME P450 2A6; CYTOCHROME P450 2E1; DNA;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; BRAZIL; CAUCASIAN; CONTROLLED STUDY; DNA EXTRACTION; ENZYME ACTIVITY; ENZYME MECHANISM; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN EXPERIMENT; MALE; POLYMERASE CHAIN REACTION; POPULATION DISTRIBUTION; POPULATION GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 33646204039     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006000200005     Document Type: Article

References (40)

1. Hasler JA, Estabrook R, Murray M et al. (1999). Human cytochromes P450. Molecular Aspects of Medicine, 20: 1-137.
2. Rautio A (2003). Polymorphic CYP2A6 and its clinical and toxicological significance. Pharmacogenomics Journal, 3: 6-7.
3. CYP Alleles Homepage [http://www.imm.ki.se/CYPalleles]. Accessed March 15, 2005.
4. Vineis P (2002). The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology, 181-182: 457-462.
5. Daly AK (2003). Pharmacogenetics of the major polymorphic metabolizing enzymes. Fundamental and Clinical Pharmacology, 17: 27-41.
6. Tricker AR (2003). Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. Toxicology, 183: 151-173.
7. Fernandez-Salgueiro P & Gonzalez FJ (1995). The CYP2A subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis. Pharmacogenetics, 5: S123-S128.
8. Yamano S, Tatsuno J & Gonzalez FJ (1990). The CYP2A3 gene product catalyzes ooumarin 7-hydroxylation in human liver microsomes. Biochemistry, 29: 1322-1329.
9. Haddidi H, Zahlsen K, Idle JR et al. (1997). A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. Food and Chemical Toxicology, 35: 903-907.
10. Oscarson M, Gullsten H, Rautio A et al. (1998). Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase. FEBS Letters, 438: 201-205.
11. Oscarson M, McLellan RA, Gullstén H et al. (1999). Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism. FEBS Letters, 460: 321-327.
12. Yang CS, Patten CJ, Ishizaki H et al. (1991). Induction, purification, and characterization of cytochrome P450IIE. Methods in Enzymology, 206: 595-601.
13. Umeno M, McBride OW, Yang CS et al. (1988). Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. Biochemistry, 27: 9006-9013.
14. Watanabe J, Hayashi S, Nakachi K et al. (1990). Pstl and Rsal RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Research, 18: 7194.
15. Hayashi S, Watanabe J & Kawajiri K (1991). Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. Journal of Biochemistry, 110: 559-565.
16. Persson I, Johansson I, Bergling H et al. (1993). Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer. FEBS Letters, 319: 207-211.
17. Garte S, Gaspari L, Alexandrie A et al. (2001). Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiology, Biomarkers and Prevention, 10: 1239-1248.
18. Rossini A, Rapozo DCM, Amorim LMF et al. (2002). Frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms in a Brazilian population. Genetics and Molecular Research, 1: 233-240.
19. Miller S, Dykes D & Polesky H (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16: 1215.
20. Wang S, Lee H, Chen K et al. (1999). Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population. Lung Cancer, 26: 27-34.
21. Sanguinetti CJ, Neto ED & Simpson AJG (1994). Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques, 17: 915-919.
22. Genepop on the Web version 3.4. [http://wbiomed.curtin.edu.au/genepop]. Accessed March 10, 2005.
23. Stellman SD, Takezaki T, Wang L et al. (2001). Smoking and lung cancer risk in American and Japanese men: an international case-control study. Cancer Epidemiology, Biomarkers and Prevention, 10: 1193-1199.
24. Castellsagué X, Muñoz N, De Stefani E et al. (1999). Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. International Journal of Cancer, 82: 657-664.
25. Wynder EL, Mushinski MH & Spivak JC (1977). Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer, 40: 1872-1878.
26. Carvalho-Silva DR, Santos FR, Rocha J et al. (2001). The phylogeography of Brazilian Y chromosome. American Journal of Human Genetics, 68: 281-286.
27. Parra FC, Amado RC, Lambertucci JR et al. (2003). Color and genomic ancestry in Brazilians. Proceedings of the National Academy of Sciences, USA, 100: 177-182.
28. Paschke T, Riefler M, Schuler-Metz A et al. (2001). Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African Americans using a new one-step PCR-RFLP genotyping method. Toxicology, 168: 259-268.
29. 450246*1A alleles in a black African population of Ghana. European Journal of Clinical Pharmacology, 60: 855-857.
30. Vasconcelos GM, Struchiner CJ & Suarez-Kurtz G (2005). CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians. Pharmacogenomics Journal, 5: 42-48.
31. Oscarson M, McLellan RA, Gullsten H et al. (1999). Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population. FEBS Letters, 448: 105-110.
32. Bourian M, Gullstén H & Legrum W (2000). Genetic polymorphism of CYP2A6 in the German population. Toxicology, 144: 129-137.
33. Kwon JT, Nakajima M, Chai S et al. (2001). Nicotine metabolism and CYP2A6 allele frequencies in Koreans. Pharmacogenetics, 11: 317-323.
34. Burim RV, Canalle R, Martinelli ALC et al. (2004). Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYPlA1 and susceptibility to cirrhosis or pancreatitis in alcoholics. Mutagenesis, 19: 291-298.
35. Nishimoto IN, Hanaoka T, Sugimura H et al. (2000). Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and non-Japanese Brazilians. Cancer Epidemiology, Biomarkers and Prevention, 9: 675-680.
36. Stephens EA, Taylor JA, Kaplan N et al. (1994). Ethnic variation in the CYP2E1 gene: polymorphism analysis in 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics, 4: 185-192.
37. Liu S, Park JY, Schantz SP et al. (2001). Elucidation of CYP2E1 5′ regulatory Rsal/Pstl allelic variants and their role in risk for oral cancer. Oral Oncology, 37: 437-445.
38. Neuhaus T, Ko Y, Lorenzen K et al. (2004). Association of cytochrome P450 2E1 polymorphisms and head and neck squamous cell cancer. Toxicology Letters, 151: 273-282.
39. Tan W, Song N, Wang G et al. (2000). Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiology, Biomarkers and Prevention, 9: 551-556.
40. Gao C, Takezaki T, Wu J et al. (2002). Interaction between cytochrome p-450 2e1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese. Cancer Epidemiology, Biomarkers and Prevention, 11: 29-34.